About Astellas Pharma US, Inc.
Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the U.S., Astellas markets products in the areas of immunology, urology, anti- infectives, cardiovascular and dermatology. For more information about Astellas Pharma US, Inc., please visit our website at http://www.astellas.com/us.
Trademarks listed belong to their respective owners.
This press release contains certain "forward-looking" statements as
that term is defined in the Private Securities Litigation Reform Act of
1995 regarding, among other things, statements relating to goals, plans,
objectives and future events. Theravance intends such forward-looking
statements to be covered by the safe harbor provisions for forward-looking
statements contained in Section 21E of the Exchange Act and the Private
Securities Litigation Reform Act of 1995. Examples of such statements
include statements relating to the goals, timing and expected results of
regulatory review, statements regarding the potential benefits and
mechanisms of action of drug candidates, the enabling capabilities of
Theravance's approach to drug discovery and its proprietary insights, and
statements concerning expectations for product candidates through
development and commercialization. These statements are based on the
current estimates and assumptions of the management of Theravance as of the
date of this press release and are subject to risks, uncertainties, changes
in circumstances, assu
|SOURCE Astellas Pharma US, Inc.|
Copyright©2007 PR Newswire.
All rights reserved